P. Kirkbride et al., CARCINOMA OF THE VAGINA - EXPERIENCE AT THE PRINCESS-MARGARET-HOSPITAL (1974-1989), Gynecologic oncology, 56(3), 1995, pp. 435-443
The charts of 153 patients with vaginal carcinoma or carcinoma in situ
seen at Princess Margaret Hospital between 1974 and 1989 were analyze
d with respect to treatment modality, radiation dose and technique, co
mplications, and survival. One hundred and twenty-eight patients were
treated with radiation therapy, of which 10 received radiation postope
ratively and 26 concomitant chemotherapy. The overall 5-year actuarial
cause-specific survival was 66%. The 5-year cause-specific survivals
by stage were Stage 0 (C-I-S) 100%, Stages I/II 77%, and Stages III/IV
56%. Late complications from treatment were infrequent and in only 12
patients were such complications classified as severe. Univariate ana
lysis indicated that size and stage of tumor, histological grade, pati
ent age, and radiation dose > 7000 cGy were significant factors in pre
dicting survival, although in a multivariate analysis only size and st
age retained significance. Fifty-one patients had a prior gynecologica
l malignancy arising 1-37 years previously, of which 34 had cervical c
ancers. Radiotherapy is an effective treatment for all stages of carci
noma of the vagina and doses of at least 7000 cGy are recommended to m
aximize tumor control. (C) 1995 Academic Press, Inc.